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ABSTRACT 
Background/Aims: Measurement of urinary sulfated bile acid (USBA) level is a 
simple urine test that reflects the degree of cholestasis in newborns. The aim of this 
study was to clarify the clinical significances of this test for liver diseases in adults. 
Methodology: We examined the relationship between USBA level in a urine sample by 
enzymatic assay and clinical parameters and postoperative complications in 27 patients 
with hepatobiliary diseases who underwent surgical procedures between 2002 and 2007. 
Results: Mean USBA in all patients before surgery was 39.8 ± 64.0 μmol/L (median 
value was 6.6). USBA level was increased in patients with cholestasis. USBA level was 
significantly correlated with serum total bile acid, total bilirubin level and serum 
hyaluronic acid level (r=0.850, 0.602 and 0.504, respectively) (p<0.05) and, 
furthermore, tended to be correlated with liver-uptake ratio (LHL15) by 
technetium-99m galactosyl human serum albumin (99mTc-GSA) scintigraphy and 
alanine aminotransferase level (r=-0.469 and 0.436, respectively but not significant). 
USBA level tended to be associated with postoperative uncontrolled ascites (p=0.050, 
not significant). Postoperative USBA level by day 7 was not changed; however, USBA 
level in patients with cholestatic diseases was decreased Conclusions: USBA is a 
simple and sensitive noninvasive test for cholestasis and also useful to predict 
postoperative uncontrolled ascites after hepatic resections.  
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ABBREVIATIONS: urinary sulfated bile acid (USBA); technetium-99m galactosyl 
human serum albumin (99mTc-GSA); indocyanine green retention rate at 15 min (ICG 
R15) 
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INTRODUCTION 
It is well known that the serum bile acid level is increased according to cholestasis 
in hepatobiliary diseases (1). This parameter is often used to investigate cholestatic 
diseases (2). Furthermore, sulfated bile acid refluxes into the serum under cholestatic 
status and is excreted in the urine (3). The urinary sulfated bile acid (USBA) level is 
thus increased and reflects the degree of cholestasis in liver diseases of animals and 
pediatric cholestatic diseases (4-7). Advantages of measuring USBA are that the test is 
noninvasive, it does not require blood samples, and it is sensitive for detecting 
cholestatic diseases at an early stage (4). Therefore, USBA has been used in animals and 
newborns.  Additionally, there is no risk of transmitting infections via blood using this 
test. We measured USAB before and after operation in patients who had hepatobiliary 
diseases with the intent of clarifying the clinical significance of USBA by comparing 
several parameters.  
. 
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METHODOLOGY 
Patients 
The subjects were 27 patients with hepatobiliary diseases who underwent surgical 
resections in the Division of Surgical Oncology, Department of Translational Medical 
Sciences, Nagasaki University Graduate School of Biomedical Sciences between 2003 
and 2007. They included 15 males and 12 females with a mean age of 67.28.5 years 
(SD, range, 50-80 years). Injured liver diseases included 10 hepatocellular carcinomas, 
2 intrahepatic cholangiocarcinomas, 6 metastatic liver tumors originating from 
colorectal carcinoma, a gall bladder carcinoma, 6 bile duct carcinomas and 2 benign 
liver tumors. The background liver diseases included chronic viral liver diseases in 10 
(including 3 cases of cirrhosis caused in 4 by hepatitis viral B and 6 by hepatitis viral C) 
and obstructive jaundice in 7 patients and normal liver function in 10.  
In our hospital, the volume of liver to be resected is estimated before surgery based 
on the results of indocyanine green retention rate at 15 min (ICG R15) using Takasaki’s 
formula (8) and liver activity at 15 minutes by technetium-99m galactosyl human serum 
albumin scintigraphy (LHL15) in case of hepatectomy (9). In case of biliary diseases 
with obstructive jaundice, the operation was postponed until the total bilirubin level was 
under 2 mg/dL. Hepatic resection was performed in 23 patients including limited 
resection in 8 patients, segmentectomy in 5, and lobectomy in 10. Four other patients 
underwent pylorus preserving pancreaticoduodenectomy. Post-operative complications 
included persistent ascites in 5 (representing massive ascites even under treatment with 
diuretics for more than two weeks), hepatic failure in 1 (represented by total bilirubin > 
3 mg/dL at day 28 postoperatively), and intra-abdominal infection in one patient. There 
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was no hospital stay in the present series. The study design was approved by the Ethics 
Review Board of our institution and a signed consent for measuring USBA was 
obtained from each subject. 
 
Measurement of USBA 
Urine samples were collected in the early morning from each patient before 
surgery when the patient was in a stable condition during hospitalization. In patients 
with obstructive jaundice and hyperbilirubinemia, samples were not collected until total 
bilirubin level was improved at less than 2 mg/dL by biliary drainage. The urine sample 
was stored at -20C before USBA assay (4, 10). USBA was measured by a 
commercially available kit, UBASTEC by Marukin Bio, Inc. (Kyoto, Japan), utilizing 
direct enzymatic assay. (10) USBA value was corrected by creatinine clearance and the 
normal value was determined as less than 10 μmol/g creatinine by laboratory data. 
Platelet count, prothrombin activity, and serum level of total bilirubin, alanine 
aminotransferase, total cholesterol or hyaluronic acid were examined by blood test.  
 
Statistical analysis 
Data were expressed as mean  SD. Data of different groups were compared using 
one-way analysis of variance (ANOVA) and examined by Student’s t-test or Dunnet’s 
multiple comparison test. Correlations between two parameters were examined by 
calculating the Pearson’s correlation coefficient. A two-tailed P value < 0.05 was 
considered significant. Statistical analyses were performed using the computer software 
STATISTICATM (StatSoft, Tulsa, OK).  
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RESULTS 
The preoperative mean and median concentrations of USBA in all patients were 
39.864.0 and 6.6μmol/g creatinine (ranging from 0.8 to 285.7μmol/g creatinine), 
respectively. The USBA level in these patients was not associated with gender or 
Child-Pugh classification (Table 1). USBA was significantly increased in patients with 
obstructive jaundice; however, USBA in chronic viral hepatitis or cirrhosis was similar 
to that in normal liver. The correlation between USBA and patient age or liver function 
tests is shown in Table 2. USBA was not associated with patient age. USBA was 
significantly correlated with the results of serum total bile acid level, total bilirubin 
level, and serum hyaluronic acid level. Furthermore, USBA tended to be correlated with 
alanine aminotransferase level and liver-uptake ratio (LHL15) by technetium-99m 
galactosyl human serum albumin (99mTc-GSA) scintigraphy.  
Figure 1 shows postoperative changes in mean USBA after hepatic resection. 
USBA level decreased at day 1 after hepatectomy and was maintained at day 7. Figure 
2 shows postoperative changes of mean USBA in each liver disease. Although USBA 
level was increased in patients with obstructive jaundice, this level was immediately 
decreased at day 1. Postoperative USBA levels were not significantly different between 
liver diseases. Preoperative USBA level in patients with postoperative uncontrolled 
ascites tended to be higher than that in patients without ascites (Table 1). Figure 3 
shows postoperative changes of mean USBA in patients with or without uncontrolled 
ascites after operation. USBA level was significantly increased at day 3 in patients with 
uncontrolled ascites, however, which was immediately improved at day 7. 
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DISCUSSION 
Although sulfated bile acid in liver cells is excreted into the bile, it is refluxed into the 
serum under cholestatic conditions (1-3). Sulfated serum bile has high water solubility 
and is immediately excreted in the urine as USBA (11). Measurement of USBA is 
expected to be a useful test for diagnosis and analysis of cholestasis in hepatobiliary 
diseases. As in previous reports (4-7), USBA was significantly correlated with serum 
bile acid level in our series. Obatake et al. (4) reported that USBA was increased in 
neonatal patients with cholestasis such as biliary atresia. They described that USBA still 
increased under conditions of cholangitis as well. In the present study, USBA was 
higher in patients with obstructive biliary diseases. In these patients, the high bilirubin 
level was improved by biliary drainage; however, USBA was still higher. Although 
USBA was correlated with higher serum bilirubin level as the present result, this 
parameter might be sensitive for congestion of bile or inflammation of bile ducts.  As 
our result indicated, USBA level in cholestatic diseases dramatically decreased and 
immediately improved after hepatectomy. Release of biliary congestion might cause 
this improvement of USBA. Although Obatake et al. reported that USBA was not 
correlated with any liver function tests and was an independent parameter to diagnose 
biliary atresia (4), USBA was also correlated with serum hyaluronic acid level or other 
liver dysfunctions in adult patients of the present study. Particularly, our previous study 
indicated that hyaluronic acid level or LHL15 by 99m-Tc GSA liver scintigraphy were 
useful functional parameters to estimate hepatocellular damage and to predict 
postoperative hepatic complications (12, 13).  USBA might be related to total parenteral 
nutrition (TPN)-associated cholestasis (4, 14). In our series, some patients were 
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examined under the condition of TPN. However, no significant relationship could be 
observed because of the small number of patients (n = 2) (not shown in result).  
       As USBA level was associated with hyaluronic acid level or LHL15 as described 
above, it is possible that USBA was able to predict or monitor postoperative 
complications. As expected, preoperative USBA or USBA at day 3 was related to 
uncontrolled ascites. This complication was likely caused by cellular damage of the 
liver. USBA may be a sensitive hepatic marker to predict postoperative liver damage. 
To our knowledge, the possibility of using this marker has not been reported. In the 
present series, hepatic failure or intraabdominal infection was observed in only one 
patient. To clarify the usefulness of USBA to predict postoperative hepatic 
complications, a larger number of patients with severe hepatic complications after 
hepatectomy must be examined.  
  Some advantages of testing USBA in comparison with measuring serum bile acid 
level include: 1) Non-invasiveness because no blood sampling is necessary. USBA test 
can be used in infants or obese patients. 2) Sampling is easy and, therefore, it can be 
applied for screening tests in a large number of subjects. 3) Lower risk of transmitting 
infections via blood for both patients and investigators in the laboratory compared to 
blood sampling (4). The disadvantages of USBA test at present are a higher cost and 
lack of rapid report. These disadvantages will be resolved with improvement of the 
system in the near future. 
In conclusion, we have demonstrated that USBA was significantly correlated with 
biliary cholestasis in hepatobiliary diseases, which were immediately improved by the 
complete resection of obstructive portions. USBA was correlated with serum bile acid 
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level and some liver functions. USBA is a simple and sensitive noninvasive test for 
cholestasis and is also useful to predict postoperative uncontrolled ascites by the hepatic 
damages after hepatic resections. 
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FIGURE LEGENDS 
 
FIGURE 1  Serial changes in USBA concentrations after hepatectomy. Data are 
expressed as means  SD. Preop., preoperative.   
 
FIGURE 2  Serial changes in USBA concentrations in each liver disease after 
hepatectomy. Preop., preoperative. Solid line shows the normal liver, long broken line 
shows the obstructive jaundice, small dotted line shows chronic viral hepatitis and long 
chain line shows cirrhosis. *: Significant difference between USBA concentration 
preoperatively and on postoperative day 3 in patients with obstructive jaundice. 
  
FIGURE 3  Serial changes in USBA concentrations in patients with or without 
uncontrolled ascites after hepatectomy. Preop., preoperative. Solid line shows negative 
ascites, and the long broken line shows positive ascites. *: Significant difference 
between USBA concentration preoperatively and on postoperative day 3 in patients 
with uncontrolled ascites. 
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TABLE 1 Relationship between USBA Concentrations and Patient Demographics 
and Postoperative Complication. 




Background liver disease 
  Normal (n=10) 
Obstructive jaundice (n=7) 










  31.1±37.0 
  
18.4±38.7 










Data are expressed as means ± SD. Data of different groups were examined by 
Student’s t-test and Dunnet’s multiple comparison test.  
*; P<0.05 vs. chronic viral hepatitis.  #; p=0.50 
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TABLE 2 Correlation between USBA Concentrations, and Patient Age or Liver 
Function Tests. 
 
 correlation coefficient (r) P value 
Age 
Serum total bile acid (μg/ml) 
Total bilirubin (mg/dL) 
Alanine aminotransferase (IU/L) 
Platelet count (/mm3) 
Total cholesterol (mg/dL) 
Prothrombin activity (%) 
























ICGR15: indocyanine green retention rate at 15 minutes 
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